Manuela A. Bergmann

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer et al. · Blood · 2009 · 333 citations

Medicine, Oncology, Pharmacotherapy +7

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia

Natali Pflug, Jasmin Bahlo, Tait D. Shanafelt et al. · Blood · 2014 · 276 citations

Medicine, Hematology, Oncology +12

Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response Rates and Progression-Free Survival (PFS) of Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL)

Michael Hallek, Guenter Fingerle-Rowson, Anna Maria Fink et al. · Blood · 2008 · 134 citations

Medicine, Oncology, Pharmacotherapy +14

Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.

Manuela A. Bergmann, Maria Elisabeth Goebeler, Michael Herold et al. · PubMed · 2005 · 130 citations

Medicine, Oncology, Pharmacology +16

First-Line Treatment with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Improves Overall Survival (OS) in Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Randomized Phase III Trial On Behalf of An International Group of Investigators and the German CLL Study Group.

Michael Hallek, Guenter Fingerle-Rowson, Anna‐Maria Fink et al. · Blood · 2009 · 90 citations

Medicine, Oncology, Pharmacotherapy +12